Stockholm - Delayed Quote SEK
CombiGene AB (publ) (COMBI.ST)
2.5900
+0.0700
+(2.78%)
At close: May 20 at 4:31:16 PM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
326
326
5,544
26,699.2820
84,041.5710
Operating Expense
47,544
47,544
44,144
46,161.3660
63,447.7780
Operating Income
-47,218
-47,218
-38,600
-19,462.0840
20,593.7930
Net Non Operating Interest Income Expense
2,340
2,340
2,935
790.1450
0.0240
Pretax Income
-44,878
-44,878
-35,665
-6,156.9310
20,964.9150
Tax Provision
0
0
0
0
0
Net Income Common Stockholders
-44,878
-44,878
-35,665
-6,156.9310
20,964.9150
Diluted NI Available to Com Stockholders
-44,878
-44,878
-35,665
-6,156.9310
20,964.9150
Basic EPS
-2.27
-2.27
-1.80
-0.31
1.21
Diluted EPS
-2.27
-2.27
-1.80
-0.31
1.21
Basic Average Shares
19,801.1970
19,801.1970
19,801.1970
19,801.1970
17,311.4140
Diluted Average Shares
19,801.1970
19,801.1970
19,801.1970
19,801.1970
17,311.4140
Total Operating Income as Reported
-47,218
-47,218
-38,600
-6,947.0750
20,964.8910
Total Expenses
47,544
47,544
44,144
46,161.3660
63,447.7780
Net Income from Continuing & Discontinued Operation
-44,878
-44,878
-35,665
-6,156.9310
20,964.9150
Normalized Income
-44,878
-44,878
-35,665
-6,156.9310
20,964.9150
Interest Income
--
--
2,939.3860
791.8270
0.0240
Interest Expense
--
--
4.8010
1.6820
0
Net Interest Income
2,340
2,340
2,935
790.1450
0.0240
EBIT
-47,218
-47,218
-38,600
-6,155.2490
20,964.9150
EBITDA
-34,220
-34,220
-35,976
-3,560.4210
23,559.7430
Reconciled Depreciation
12,998
12,998
2,624
2,594.8280
2,594.8280
Net Income from Continuing Operation Net Minority Interest
-44,878
-44,878
-35,665
-6,156.9310
20,964.9150
Normalized EBITDA
-34,220
-34,220
-35,976
-3,560.4210
23,559.7430
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 5/25/2015
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade